{"url":"https://lda.senate.gov/api/v1/filings/b955ec5d-e240-4e20-b01f-b836f3ee5ea9/","filing_uuid":"b955ec5d-e240-4e20-b01f-b836f3ee5ea9","filing_type":"RR","filing_type_display":"Registration","filing_year":2022,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b955ec5d-e240-4e20-b01f-b836f3ee5ea9/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Robert Horne","dt_posted":"2022-07-20T14:44:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"6905 Forest Hill Drive","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"University Park","registrant_state":"MD","registrant_zip":"20782","registrant":{"id":401105585,"url":"https://lda.senate.gov/api/v1/registrants/401105585/","house_registrant_id":44708,"name":"FOREST HILL CONSULTING","description":"Health policy, market, and advocacy consulting services","address_1":"6905 Forest Hill Drive","address_2":null,"address_3":null,"address_4":null,"city":"University Park","state":"MD","state_display":"Maryland","zip":"20782","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT HORNE","contact_telephone":"+1 703-217-8748","dt_updated":"2026-02-02T21:40:19.801493-05:00"},"client":{"id":52374,"url":"https://lda.senate.gov/api/v1/clients/52374/","client_id":52374,"name":"THE PARTNERSHIP TO FIGHT INFECTIOUS DISEASE (PFID)","general_description":"Advocacy for issues related to infectious like AMR","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"The need for Congress to pass financial incentives for the purpose of encouraging the development of new and novel antibiotics as well as other steps to address AMR.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":141060,"prefix":"mr","prefix_display":"MR.","first_name":"ROBERT","nickname":null,"middle_name":"JAMES","last_name":"HORNE","suffix":null,"suffix_display":null},"covered_position":"Professional Staff - Energy and Commerce Committee; Senior Legislative Aide - Rep Phil Gingrey","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}